Publication: COVID-19 and CAR T cells: a report on current challenges and future directions from the EPICOVIDEHA survey by EHA-IDWP.
Identifiers
Date
2022
Authors
Busca, Alessandro
Salmanton-García, Jon
Corradini, Paolo
Marchesi, Francesco
Cabirta, Alba
Di Blasi, Roberta
Dulery, Remy
Lamure, Sylvain
Farina, Francesca
Weinbergerová, Barbora
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Metrics
Export
Abstract
The EHA-IDWP developed an observational registry collecting data on COVID-19 infection in patients who received CAR T-cell therapy. Prevalence of COVID-19 was 4.8%, and overall mortality was 50%, highlighting the need for prevention of infection in these patients.
Description
MeSH Terms
COVID-19
Humans
Immunotherapy, Adoptive
Receptors, Chimeric Antigen
T-Lymphocytes
Humans
Immunotherapy, Adoptive
Receptors, Chimeric Antigen
T-Lymphocytes